MGRX vs PLTR · rev $456.0K vs P/E 584, rev $3.57B
Mangoceuticals, Inc. Common Stock (MGRX) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Latest reported PLTR revenue for 2026-06-30 was $3.57B. Net income was $1.93B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
MGRX currently screens at market cap $16.3M. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the MGRX and PLTR stock pages for the full models.
Not investment advice.